GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer — Stella

Home/Breast Cancer Invasive/

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer Invasive trials

Trial locations(1 site)

China

Shanghai Jiaotong University School of Medicine affiliated Ruijin Hospital, Shanghai

Key details

Sponsor

Shanghai Jiao Tong University School of Medicine

Enrollment target

~50 participants

Started

November 2024

Primary completion

November 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 65 Years

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.